Seer Q1 2026 Earnings Call Summary

In its Q1 2026 earnings call, Seer (SEER) highlighted progress in innovation, commercial strategy, and strategic partnerships. The company doubled independent publications validating its proteomics platform year-over-year and announced a new biobank collaboration with Precision Health Research Singapore and Thermo Fisher.

By Motley Fool Transcribing, The Motley Fool Thu, May 14, 2026 at 6:18 PM GMT+3 27 min read · Yahoo Finance · May 14, 2026, 15:18 UTC

Seer Q1 2026 Earnings Call Summary

Topics: company update financial results proteomics technology

Read the full article at Yahoo Finance

More World news

SpaceX Partners with Qualcomm to Launch Starlink Mobile Cellular Service Motley Fool · November 12, 2026, 15:21 UTC
Blast Resources Appoints Andy Yackulic as CEO to Lead Uranium Exploration PR Newswire · November 12, 2026, 15:26 UTC
FMC Corporation Shares Decline 13% in Thursday Trading Seeking Alpha · November 12, 2026, 15:22 UTC
U.S. Stock Indices Decline Following Nvidia CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 15:23 UTC
EY Report Outlines Three Fundamental Shifts Required for Future-Ready Health Systems by 2040 PR Newswire · November 12, 2026, 15:24 UTC
ProLift Garage Doors Expands Franchise Services and Support Initiatives PR Newswire · November 12, 2026, 15:24 UTC
Pomerantz Law Firm Investigates Cerebras Systems Inc. Over Potential Securities Fraud PR Newswire · November 12, 2026, 15:25 UTC
CEZ Reports 9M Revenue Growth and 24% Increase in Net Income Seeking Alpha · November 12, 2026, 15:05 UTC
BlueMatrix Completes Acquisition of AI-Enabled Research Platform Aiera PR Newswire · November 12, 2026, 15:15 UTC
U.S. Lawmakers Respond to Jensen Huang's Resignation as Nvidia CEO Seeking Alpha · November 12, 2026, 15:12 UTC